Impact of Age and Gender on Plasma N-Terminal Pro-B-Type Natriuretic Peptide
DOI:
https://doi.org/10.46966/msjar.v5i3.202Keywords:
N-terminal pro -B-type Natriuretic Peptide, Age, GenderAbstract
Background: Age has a significant impact on the body, which may affect plasma concentrations of NT-proBNP. (e.g., increased fibrosis and heart stiffness, worse renal function, and lower lean body mass). Elevated NT-proBNP levels are commonly reported in advanced age groups, even in seemingly healthy individuals. On the other hand, Some studies suggest that Women have larger plasma concentrations of natriuretic peptides than men. Objective: In a population-based research, we wanted to look at how age and gender affected the plasma N-terminal pro -B-type natriuretic peptide (NT.proBNP) concentration in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) with negative coronary artery disease (CAD) confirmed by percutaneous coronary intervention (PCI). Methods: Electrocardiogram (ECG), serum troponin I, 2D echocardiography, plasma NT.proBNP, and PCI were performed on 48 Iraqi patients from Al-Najaf Center for Cardiac Surgery and Transcatheter Therapy/ Al-Sader Teaching Hospital, department of coronary intervention who have non-ST elevation acute coronary syndrome NSTE-ACS with negative CAD (< 50% arterial blockage) seen by PCI. This group of people had sinus rhythm, no renal or pulmonary illness, normal systolic function, and no valvular abnormality. Results: Within this group, Age differences existed in NT.proBNP distribution. Age-related increases in NT.proBNP were statistically significant. Regarding gender, our results had no statistically significant difference in NT.proBNP between males and females. Conclusions: Our study concluded that Plasma NT.proBNP level increases with age among patients with NSTE-ACS and negative CAD, while there is no significant difference in this hormone between males and females.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Fatima F. Al-Muhanna, Amina A. B. Al-Dejeli

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















